Relationship between enzyme properties and disease progression in Canavan disease

[1]  Xuefan Gu,et al.  Two novel missense mutations in the aspartoacylase gene in a Chinese patient with congenital Canavan disease , 2010, Brain and Development.

[2]  A. Bahsas,et al.  Molecular mechanism for the denaturation of proteins by urea. , 2009, Biochemistry.

[3]  S. Englander,et al.  Urea, but not guanidinium, destabilizes proteins by forming hydrogen bonds to the peptide group , 2009, Proceedings of the National Academy of Sciences.

[4]  R. Sanishvili,et al.  Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue. , 2008, Biochemistry.

[5]  N. Pattabiraman,et al.  Mutational analysis of aspartoacylase: Implications for Canavan Disease , 2007, Brain Research.

[6]  R. Viola,et al.  Characterization of Human Aspartoacylase: the brain enzyme responsible for Canavan disease , 2006, Biochemistry.

[7]  D. Shera,et al.  Mild‐onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene , 2006, Annals of neurology.

[8]  C. Yalçınkaya,et al.  Atypical MRI findings in Canavan disease: a patient with a mild course. , 2005, Neuropediatrics.

[9]  D. Zafeiriou,et al.  Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease. , 2005, Neuropediatrics.

[10]  J. Pearce.  Canavan’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  F. Bamforth,et al.  Mild Elevation of N-Acetylaspartic Acid and Macrocephaly: Diagnostic Problem , 2003, Journal of child neurology.

[12]  Roger A. Moore,et al.  Purification and preliminary characterization of brain aspartoacylase. , 2003, Archives of biochemistry and biophysics.

[13]  R. De Gasperi,et al.  Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease , 2002, Journal of Inherited Metabolic Disease.

[14]  A. Shaag,et al.  The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients , 1999, Journal of Inherited Metabolic Disease.

[15]  I. Rapin,et al.  The clinical course of Canavan disease. , 1998, Pediatric neurology.

[16]  Y. Anikster,et al.  The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients. , 1995, American journal of human genetics.

[17]  R. Kaul,et al.  Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. , 1994, Genomics.

[18]  R. Kaul,et al.  Canavan disease: Biochemical and molecular studies , 1993, Journal of Inherited Metabolic Disease.

[19]  R. Matalon,et al.  Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. , 1988, American journal of medical genetics.

[20]  J. Zachary,et al.  Spongy Degeneration of the Central Nervous System in Two Canine Littermates , 1985, Veterinary pathology.

[21]  R. Viola,et al.  Purification of aspartase and aspartokinase-homoserine dehydrogenase I from Escherichia coli by dye-ligand chromatography. , 1985, Analytical biochemistry.

[22]  M. J. Maisels,et al.  Spongy degeneration of the central nervous system (Van Bogaert-Bertrand type?) in a newborn infant , 1977, Acta Neuropathologica.

[23]  M. Adachi,et al.  Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review. , 1973, Human pathology.

[24]  A. Fantiš,et al.  [Schilder's encephalitis periaxialis diffusa]. , 1950, Casopis lekaru ceskych.

[25]  M. M. Canavan.  SCHILDER'S ENCEPHALITIS PERIAXIALIS DIFFUSA: REPORT OF A CASE IN A CHILD AGED SIXTEEN AND ONE-HALF MONTHS , 1931 .

[26]  J. Globus,et al.  PROGRESSIVE DEGENERATIVE SUBCORTICAL ENCEPHALOPATHY: (SCHILDER'S DISEASE) , 1928 .

[27]  S. Tsujino,et al.  Missense mutation (I143T) in a Japanese patient with Canavan disease , 1998, Human mutation.

[28]  R. Kaul,et al.  Novel (cys152>arg) missense mutation in an Arab patient with Canavan disease , 1995, Human mutation.

[29]  R. Kaul,et al.  Canavan disease: mutations among Jewish and non-Jewish patients. , 1994, American journal of human genetics.